| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |